Shenzhen Kangtai Biological Products Co., Ltd.

XSEC:300601 Stock Report

Market Cap: CN¥21.3b

Shenzhen Kangtai Biological Products Future Growth

Future criteria checks 5/6

Shenzhen Kangtai Biological Products is forecast to grow earnings and revenue by 39.8% and 24.6% per annum respectively. EPS is expected to grow by 41% per annum. Return on equity is forecast to be 10.6% in 3 years.

Key information

39.8%

Earnings growth rate

41.0%

EPS growth rate

Biotechs earnings growth43.6%
Revenue growth rate24.6%
Future return on equity10.6%
Analyst coverage

Good

Last updated13 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300601 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20265,1361,2741,2691,2858
12/31/20254,5341,1716761,4729
12/31/20243,1676285259494
9/30/20243,03151575644N/A
6/30/20242,949516133751N/A
3/31/20243,181710128828N/A
12/31/20233,4778613151,033N/A
9/30/20233,057361121911N/A
6/30/20233,060257-112777N/A
3/31/20233,034-201-326735N/A
1/1/20233,157-133-765546N/A
9/30/20223,840430-1,062953N/A
6/30/20224,4281,047-7491,711N/A
3/31/20224,2471,512-8311,770N/A
1/1/20223,6521,263-8881,652N/A
9/30/20213,2181,282-1,349891N/A
6/30/20212,443756-1,361463N/A
3/31/20212,361702-1,219337N/A
12/31/20202,261679-787440N/A
9/30/20201,96957778746N/A
6/30/20202,006576-35407N/A
3/31/20201,779477155441N/A
12/31/20191,943575119506N/A
9/30/20191,91149082446N/A
6/30/20191,761407-23387N/A
3/31/20191,955426-114325N/A
12/31/20182,017436-7336N/A
9/30/20181,867435-32281N/A
6/30/20181,756431N/A277N/A
3/31/20181,418296N/A202N/A
12/31/20171,161215N/A154N/A
9/30/20171,006168N/A99N/A
6/30/2017816101N/A35N/A
3/31/201755252N/A41N/A
12/31/201655286N/A78N/A
9/30/201646086N/A165N/A
12/31/201545363N/A278N/A
12/31/201430331N/A112N/A
12/31/20132512N/A26N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300601's forecast earnings growth (39.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 300601's earnings (39.8% per year) are forecast to grow faster than the CN market (25.9% per year).

High Growth Earnings: 300601's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300601's revenue (24.6% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 300601's revenue (24.6% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300601's Return on Equity is forecast to be low in 3 years time (10.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y